Circulating Biomarkers and Cardiac Structure and Function in Rheumatoid Arthritis

Background: Rheumatoid arthritis (RA) increases the risk for abnormalities of the cardiac structure and function, which may lead to heart failure (HF). Studying the association between circulating biomarkers and echocardiographic parameters is important to screen patients with RA with a higher risk...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Masatake Kobayashi, Maria Betânia Ferreira, Rita Quelhas Costa, Tomás Fonseca, José Carlos Oliveira, António Marinho, Henrique Cyrne Carvalho, Nicolas Girerd, Patrick Rossignol, Faiez Zannad, Patrícia Rodrigues, João Pedro Ferreira
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/3fe8a12e6a0d42de9f6ee17b76f28cb2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3fe8a12e6a0d42de9f6ee17b76f28cb2
record_format dspace
spelling oai:doaj.org-article:3fe8a12e6a0d42de9f6ee17b76f28cb22021-11-18T06:17:35ZCirculating Biomarkers and Cardiac Structure and Function in Rheumatoid Arthritis2297-055X10.3389/fcvm.2021.754784https://doaj.org/article/3fe8a12e6a0d42de9f6ee17b76f28cb22021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcvm.2021.754784/fullhttps://doaj.org/toc/2297-055XBackground: Rheumatoid arthritis (RA) increases the risk for abnormalities of the cardiac structure and function, which may lead to heart failure (HF). Studying the association between circulating biomarkers and echocardiographic parameters is important to screen patients with RA with a higher risk of cardiac dysfunction.Aim: To study the association between circulating biomarkers and echocardiographic parameters in patients with RA.Methods: Echocardiography was performed in 355 patients with RA from RA Porto cohort and the associations between echocardiographic characteristics and 94 circulating biomarkers were assessed. These associations were also assessed in the Metabolic Road to Diastolic Heart Failure (MEDIA-DHF) [392 patients with HF with preserved ejection fraction (HFpEF)] and the Suivi Temporaire Annuel Non-Invasif de la Santé des Lorrains Assurés Sociaux (STANISLAS) (1,672 healthy population) cohorts.Results: In the RA Porto cohort, mean age was 58 ± 13 years, 23% were males and mean RA duration was 12 ± 10 years. After adjustment and multiple testing correction, left ventricular mass index (LVMi), left atrial volume index (LAVi), and E/e′ were independently associated with biomarkers reflecting inflammation [i.e., bone morphogenetic protein 9 (BMP9), pentraxin-related protein 3 (PTX3), tumor necrosis factor receptor superfamily member 11a (TNFRSF11A)], extracellular matrix remodeling [i.e., placental growth factor (PGF)], congestion [i.e., N-terminal pro-brain natriuretic peptide (NT-proBNP), adrenomedullin (ADM)], and myocardial injury (e.g., troponin). Greater LVMi [hazard ratio (HR) (95% CI) per 1 g/m2 = 1.03 (1.02–1.04), p < 0.001], LAVi [HR (95% CI) per 1 ml/m2 = 1.03 (1.01–1.06), p < 0.001], and E/e′ [HR (95% CI) per 1 = 1.08 (1.04–1.13), p < 0.001] were associated with higher rates of cardiovascular events. These associations were externally replicated in patients with HFpEF and asymptomatic individuals.Conclusion: Circulating biomarkers reflecting inflammation, extracellular matrix remodeling, congestion, and myocardial injury were associated with underlying alterations of cardiac structure and function. Biomarkers might be used for the screening of cardiac alterations in patients with RA.Masatake KobayashiMaria Betânia FerreiraMaria Betânia FerreiraMaria Betânia FerreiraRita Quelhas CostaTomás FonsecaJosé Carlos OliveiraAntónio MarinhoAntónio MarinhoHenrique Cyrne CarvalhoHenrique Cyrne CarvalhoHenrique Cyrne CarvalhoNicolas GirerdPatrick RossignolFaiez ZannadPatrícia RodriguesPatrícia RodriguesPatrícia RodriguesJoão Pedro FerreiraJoão Pedro FerreiraFrontiers Media S.A.articlerheumatoid arthritisheart failure with preserved ejection fractionechocardiogramcirculating biomarkersprognosisDiseases of the circulatory (Cardiovascular) systemRC666-701ENFrontiers in Cardiovascular Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic rheumatoid arthritis
heart failure with preserved ejection fraction
echocardiogram
circulating biomarkers
prognosis
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle rheumatoid arthritis
heart failure with preserved ejection fraction
echocardiogram
circulating biomarkers
prognosis
Diseases of the circulatory (Cardiovascular) system
RC666-701
Masatake Kobayashi
Maria Betânia Ferreira
Maria Betânia Ferreira
Maria Betânia Ferreira
Rita Quelhas Costa
Tomás Fonseca
José Carlos Oliveira
António Marinho
António Marinho
Henrique Cyrne Carvalho
Henrique Cyrne Carvalho
Henrique Cyrne Carvalho
Nicolas Girerd
Patrick Rossignol
Faiez Zannad
Patrícia Rodrigues
Patrícia Rodrigues
Patrícia Rodrigues
João Pedro Ferreira
João Pedro Ferreira
Circulating Biomarkers and Cardiac Structure and Function in Rheumatoid Arthritis
description Background: Rheumatoid arthritis (RA) increases the risk for abnormalities of the cardiac structure and function, which may lead to heart failure (HF). Studying the association between circulating biomarkers and echocardiographic parameters is important to screen patients with RA with a higher risk of cardiac dysfunction.Aim: To study the association between circulating biomarkers and echocardiographic parameters in patients with RA.Methods: Echocardiography was performed in 355 patients with RA from RA Porto cohort and the associations between echocardiographic characteristics and 94 circulating biomarkers were assessed. These associations were also assessed in the Metabolic Road to Diastolic Heart Failure (MEDIA-DHF) [392 patients with HF with preserved ejection fraction (HFpEF)] and the Suivi Temporaire Annuel Non-Invasif de la Santé des Lorrains Assurés Sociaux (STANISLAS) (1,672 healthy population) cohorts.Results: In the RA Porto cohort, mean age was 58 ± 13 years, 23% were males and mean RA duration was 12 ± 10 years. After adjustment and multiple testing correction, left ventricular mass index (LVMi), left atrial volume index (LAVi), and E/e′ were independently associated with biomarkers reflecting inflammation [i.e., bone morphogenetic protein 9 (BMP9), pentraxin-related protein 3 (PTX3), tumor necrosis factor receptor superfamily member 11a (TNFRSF11A)], extracellular matrix remodeling [i.e., placental growth factor (PGF)], congestion [i.e., N-terminal pro-brain natriuretic peptide (NT-proBNP), adrenomedullin (ADM)], and myocardial injury (e.g., troponin). Greater LVMi [hazard ratio (HR) (95% CI) per 1 g/m2 = 1.03 (1.02–1.04), p < 0.001], LAVi [HR (95% CI) per 1 ml/m2 = 1.03 (1.01–1.06), p < 0.001], and E/e′ [HR (95% CI) per 1 = 1.08 (1.04–1.13), p < 0.001] were associated with higher rates of cardiovascular events. These associations were externally replicated in patients with HFpEF and asymptomatic individuals.Conclusion: Circulating biomarkers reflecting inflammation, extracellular matrix remodeling, congestion, and myocardial injury were associated with underlying alterations of cardiac structure and function. Biomarkers might be used for the screening of cardiac alterations in patients with RA.
format article
author Masatake Kobayashi
Maria Betânia Ferreira
Maria Betânia Ferreira
Maria Betânia Ferreira
Rita Quelhas Costa
Tomás Fonseca
José Carlos Oliveira
António Marinho
António Marinho
Henrique Cyrne Carvalho
Henrique Cyrne Carvalho
Henrique Cyrne Carvalho
Nicolas Girerd
Patrick Rossignol
Faiez Zannad
Patrícia Rodrigues
Patrícia Rodrigues
Patrícia Rodrigues
João Pedro Ferreira
João Pedro Ferreira
author_facet Masatake Kobayashi
Maria Betânia Ferreira
Maria Betânia Ferreira
Maria Betânia Ferreira
Rita Quelhas Costa
Tomás Fonseca
José Carlos Oliveira
António Marinho
António Marinho
Henrique Cyrne Carvalho
Henrique Cyrne Carvalho
Henrique Cyrne Carvalho
Nicolas Girerd
Patrick Rossignol
Faiez Zannad
Patrícia Rodrigues
Patrícia Rodrigues
Patrícia Rodrigues
João Pedro Ferreira
João Pedro Ferreira
author_sort Masatake Kobayashi
title Circulating Biomarkers and Cardiac Structure and Function in Rheumatoid Arthritis
title_short Circulating Biomarkers and Cardiac Structure and Function in Rheumatoid Arthritis
title_full Circulating Biomarkers and Cardiac Structure and Function in Rheumatoid Arthritis
title_fullStr Circulating Biomarkers and Cardiac Structure and Function in Rheumatoid Arthritis
title_full_unstemmed Circulating Biomarkers and Cardiac Structure and Function in Rheumatoid Arthritis
title_sort circulating biomarkers and cardiac structure and function in rheumatoid arthritis
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/3fe8a12e6a0d42de9f6ee17b76f28cb2
work_keys_str_mv AT masatakekobayashi circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
AT mariabetaniaferreira circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
AT mariabetaniaferreira circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
AT mariabetaniaferreira circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
AT ritaquelhascosta circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
AT tomasfonseca circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
AT josecarlosoliveira circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
AT antoniomarinho circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
AT antoniomarinho circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
AT henriquecyrnecarvalho circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
AT henriquecyrnecarvalho circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
AT henriquecyrnecarvalho circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
AT nicolasgirerd circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
AT patrickrossignol circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
AT faiezzannad circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
AT patriciarodrigues circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
AT patriciarodrigues circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
AT patriciarodrigues circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
AT joaopedroferreira circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
AT joaopedroferreira circulatingbiomarkersandcardiacstructureandfunctioninrheumatoidarthritis
_version_ 1718424531375226880